Patent · US Active

2,3-dihydroisoindole-1-carboxamides useful as ROR-gamma modulators

US11034654B2 · kind B2 · utility

0Cited by

2References

12Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Sarah Lever · Mölndal, SE
Frank Narjes · Ariccia, IT
Roine Ingemar Olsson · Mölndal, SE
Stefan Von Berg · Mölndal, SE

Key dates

Filing date	Jun 13, 2018
Grant date	Jun 15, 2021
Priority date	—
Expiry date	Jun 13, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present specification provides a compound of formula (I): or a pharmaceutically acceptable salt thereof; a process for preparing such a compound; and to the use of such a compound in the treatment of an RORγ and/or RORγt mediated disease state.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.